Researchmoz added Most up-to-date research on “Connected Drug Delivery Devices Market: Will Western Europe be Able to Beat the Adoption Rate of North America in the Coming Years?: Global Industry Analysis & Opportunity Assessment (2015 – 2027)” to its huge collection of research reports.
The growing healthcare expenditure provides significant opportunities to hospitals and companies in generating higher revenues. According to the Organization for Economic Cooperation and Development (OECD), the spending on healthcare is estimated to reach US$ 10 trillion by 2020. The healthcare spending in most of the European countries is growing faster than their GDP. According to the U.S. governments center for Medicare and Medicaid Services (CMS) the healthcare expenditure has risen approximately by 7% and is expected to cross US$ 2 trillion. The Congressional Budget Office states that if the growth in healthcare spending continues at this rate, the CMS spending and private health cost would increase approximately to 25% of the GDP.
Get Research Summary of the Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1869384
For minimizing the healthcare costs and improve the quality of life, countries across the world are seeking to shift the place of care from healthcare facilities to wherever the patients happen to be during their normal day. Half of all the healthcare will take place outside the healthcare facilities within the decade. In many cases, the future of healthcare will be environments such as the home, workplace, school, caf, or gym, with the patients responsible for the administration of their therapy. With the typical frequency for a self-injectable biologic ranging from one week to every month or quarter, devices that contain and deliver a drug must be highly intuitive. This trend will continue to accelerate over the next decade, as payers and providers will seek greater access to real-time, cloud-based data that can accurately assess how patients with a chronic disease adhere to their assigned drug regime.
North America will take the lead in the market in the long run with the maximum adoption
Significant focus on shifting to value-based reimbursement model are likely to reduce healthcare costs, which is over 17% of total GDP and health services financing sources witnessing an increase from private sources and decrease in public subsidies is expected to have a major impact on the
Health service providers increasingly collaborating with customers are expected to demonstrate clinical and financial benefit of services and the penetration of artificial intelligence technologies and big data analytics in health technologies, especially for real-time decision making to manage chronic diseases will pave way for future prospects for the market in North America in the near future. Vendors achieving economies of scale by leveraging large customer base and maintaining leading market position are expected to take the market forward in the long run. High geriatric population in the U.S. is anticipated to boost the demand for home healthcare and patient monitoring devices and services in the region and thus, augur well for the market growth in the region.
To Browse a Full Report with TOC: https://www.researchmoz.us/connected-drug-delivery-devices-market-will-western-europe-be-able-to-beat-the-adoption-rate-of-north-america-in-the-coming-years-global-industry-analysis-and-opportunity-assessment-2015-2027-report.html/toc
Western Europe is expected to closely follow North America in the coming years
Countries such as France, Germany, Italy, and Spain are expected to witness fluctuating demand for connected drug delivery devices in the coming years. France has high potential market but adoption of mobile health is average showing more reluctant to embrace digitalization of healthcare. The implementation of mobile health and related connected drug delivery devices is expected to present considerable challenges, including technological barriers, organizational challenges, confidentiality concerns and unplanned aftereffects. German consumers willingness to invest in their well-being and fast data networks is providing fertile ground for mHealth and connected drug delivery devices market growth. Health insurers in Germany have not yet introduced comprehensive reimbursement for m-health applications and connected drug delivery devices, any such strategic changes to acquire larger set of customer will be focused on younger, healthy consumers willing to pay for these services. This might adversely impact the market growth in the region.
Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Market Inclusion and Exclusion
Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1869384
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket Ghumare,
Toll Free: 866-997-4948 (US-CANADA)
Follow us on LinkedIn @ bit.ly/1TBmnVG
Follow us on Blogger @ https://marketnewstoday24.blogspot.com/